Has Barbara Kage received payments from drug or device companies?

Yes. Drug and device makers reported $21,389 in general payments to Barbara Kage across 889 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Barbara Kage did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Barbara Kage come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Barbara Kage

Rheumatology · Manchester, CTNPI 1427043538

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $13,000 of the $21,389 with a category attached, or 60.8%. 39 manufacturers reported payments, led by Amgen at 45.2% of the total. Reporting peaked in 2023 at $8,528 and has fallen 67.2% since, to $2,795 in 2025.

$21,389in general payments, 2019–2025

Across 889 payments — averaging $24.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$10K
Johnson & Johnson$3K
AbbVie$2K
Novartis$1K
UCB, Inc.$1K
Mallinckrodt Hospital Products Inc.$1K
plus $4K from 33 others

What the payments were for

Consulting fees$7504%
Speaking & faculty fees$6,75032%
Food & beverage$13,00061%
Education$8894%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	140	$9,665
Johnson & Johnson(2 entities)	274	$2,511
AbbVie	107	$1,559
Novartis	57	$1,131
UCB, Inc.	67	$1,117
Mallinckrodt Hospital Products Inc.	70	$1,074
Lilly USA, LLC	34	$787
AstraZeneca(2 entities)	16	$637
Pfizer	16	$354
Aurinia Pharma U.S., Inc.	13	$303
E.r. Squibb & Sons, L.L.C.	12	$295
Genentech USA, Inc.	11	$283
Regeneron Healthcare Solutions, Inc.	11	$274
GSK	11	$242
Sobi, Inc	5	$114
Sanofi	3	$92
ANI Pharmaceuticals, Inc.	2	$88
CSL Behring	3	$84
Kiniksa Pharmaceuticals, Ltd.	3	$82
Sandoz	3	$73
Boehringer Ingelheim	3	$66
Organon	3	$63
Fresenius Kabi USA, LLC	2	$57
Mallinckrodt Enterprises LLC	3	$46
Biocryst US Sales Co., LLC	2	$46
Hikma Pharmaceuticals USA	2	$35
Actelion Pharmaceuticals US, Inc.	2	$33
Bristol Myers Squibb	2	$32
Kiniksa Pharmaceuticals International, PLC	1	$31
Medexus Pharma, Inc.	2	$28
Kyowa Kirin, Inc.	1	$28
Scilex Pharmaceuticals Inc.	1	$25
Antares Pharma, Inc.	1	$24
Cumberland Pharmaceuticals, Inc.	1	$22
Ultragenyx Pharmaceutical Inc.	1	$20
Mckesson Medical-surgical, Inc.	1	$20
Eyevance Pharmaceuticals LLC	1	$17
Mission Pharmacal Company	1	$16
Alk-abello, Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tavneos$1,763
SAPHNELO$333
COSENTYX$237
TALTZ$101

How this compares

$21,389 in reported general payments places this provider in the 85th percentile of 118 rheumatology providers in Connecticut.

See all rheumatology providers in Connecticut →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Enbrel SureclickEtanercept	14	$280,043
Orencia ClickjectAbatacept	11	$84,059
Cevimeline Hcl	15	$5,812
Hydroxychloroquine Sulfate	80	$3,530
MethotrexateMethotrexate Sodium	40	$1,703
Prednisone	38	$441
Methylprednisolone	20	$89

Paid to pharmacies, not to this prescriber.

Other rheumatology in Manchester

Kenneth MillerDanbury$873K
Robert SchoenGuilford$638K
Bret SohnStamford$447K
Fotios KoumpourasNorth Haven$314K
James SeiboldFarmington$300K
Michael SpiegelDanbury$215K
John MagaldiTorrington$157K
Archana SharmaBristol$98K
Richard RoseffDanbury$84K
Beth ValashinasOrange$81K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →